

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | gamma-aminobutyric acid transport (GO:0015812) | 4.56496332 |
| 2 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.30479113 |
| 3 | regulation of cilium movement (GO:0003352) | 4.20357231 |
| 4 | epithelial cilium movement (GO:0003351) | 4.15729691 |
| 5 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.09776055 |
| 6 | cilium movement (GO:0003341) | 4.09614342 |
| 7 | behavioral response to nicotine (GO:0035095) | 4.06190229 |
| 8 | nonmotile primary cilium assembly (GO:0035058) | 4.01488285 |
| 9 | postsynaptic membrane organization (GO:0001941) | 3.95380806 |
| 10 | axoneme assembly (GO:0035082) | 3.82843435 |
| 11 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.70823865 |
| 12 | axonemal dynein complex assembly (GO:0070286) | 3.56841725 |
| 13 | protein localization to cilium (GO:0061512) | 3.54130712 |
| 14 | neuronal action potential propagation (GO:0019227) | 3.47584921 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.44141064 |
| 16 | protein polyglutamylation (GO:0018095) | 3.37193980 |
| 17 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.35520496 |
| 18 | transmission of nerve impulse (GO:0019226) | 3.34736374 |
| 19 | cilium morphogenesis (GO:0060271) | 3.32893224 |
| 20 | cilium organization (GO:0044782) | 3.30621317 |
| 21 | intraciliary transport (GO:0042073) | 3.30322148 |
| 22 | cilium assembly (GO:0042384) | 3.26965619 |
| 23 | cellular ketone body metabolic process (GO:0046950) | 3.21495172 |
| 24 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.21154607 |
| 25 | synaptic vesicle maturation (GO:0016188) | 3.18326609 |
| 26 | detection of light stimulus involved in visual perception (GO:0050908) | 3.17375524 |
| 27 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.17375524 |
| 28 | nucleobase catabolic process (GO:0046113) | 3.15056751 |
| 29 | photoreceptor cell maintenance (GO:0045494) | 3.13366214 |
| 30 | dendritic spine morphogenesis (GO:0060997) | 3.12733653 |
| 31 | presynaptic membrane assembly (GO:0097105) | 3.12511188 |
| 32 | regulation of microtubule-based movement (GO:0060632) | 3.09617505 |
| 33 | protein localization to synapse (GO:0035418) | 3.09176160 |
| 34 | vocalization behavior (GO:0071625) | 3.07315625 |
| 35 | cellular biogenic amine catabolic process (GO:0042402) | 3.07267638 |
| 36 | amine catabolic process (GO:0009310) | 3.07267638 |
| 37 | indolalkylamine metabolic process (GO:0006586) | 3.04734598 |
| 38 | synaptic transmission, glutamatergic (GO:0035249) | 3.03869158 |
| 39 | response to pheromone (GO:0019236) | 3.02632980 |
| 40 | neuron cell-cell adhesion (GO:0007158) | 3.01459937 |
| 41 | kynurenine metabolic process (GO:0070189) | 2.95743741 |
| 42 | auditory behavior (GO:0031223) | 2.93948391 |
| 43 | presynaptic membrane organization (GO:0097090) | 2.93211561 |
| 44 | indolalkylamine catabolic process (GO:0046218) | 2.91897725 |
| 45 | tryptophan catabolic process (GO:0006569) | 2.91897725 |
| 46 | indole-containing compound catabolic process (GO:0042436) | 2.91897725 |
| 47 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.91232119 |
| 48 | behavioral response to ethanol (GO:0048149) | 2.89374550 |
| 49 | ketone body metabolic process (GO:1902224) | 2.89345775 |
| 50 | neural tube formation (GO:0001841) | 2.83651357 |
| 51 | reflex (GO:0060004) | 2.80549487 |
| 52 | membrane depolarization during action potential (GO:0086010) | 2.80270677 |
| 53 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.79528680 |
| 54 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.74527494 |
| 55 | startle response (GO:0001964) | 2.72616329 |
| 56 | glycosphingolipid biosynthetic process (GO:0006688) | 2.71415795 |
| 57 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.70040444 |
| 58 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.67143519 |
| 59 | axonal fasciculation (GO:0007413) | 2.65069955 |
| 60 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.64443659 |
| 61 | regulation of collateral sprouting (GO:0048670) | 2.63813408 |
| 62 | central nervous system neuron axonogenesis (GO:0021955) | 2.63080235 |
| 63 | response to misfolded protein (GO:0051788) | 2.62790576 |
| 64 | neuron-neuron synaptic transmission (GO:0007270) | 2.62724699 |
| 65 | regulation of neurotransmitter uptake (GO:0051580) | 2.62320320 |
| 66 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.61135825 |
| 67 | microtubule bundle formation (GO:0001578) | 2.59482873 |
| 68 | glutamate receptor signaling pathway (GO:0007215) | 2.56793434 |
| 69 | retinal cone cell development (GO:0046549) | 2.56041659 |
| 70 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.54991036 |
| 71 | C4-dicarboxylate transport (GO:0015740) | 2.54712284 |
| 72 | signal peptide processing (GO:0006465) | 2.54619783 |
| 73 | sperm motility (GO:0030317) | 2.54580063 |
| 74 | adult walking behavior (GO:0007628) | 2.53680959 |
| 75 | behavioral fear response (GO:0001662) | 2.52639039 |
| 76 | behavioral defense response (GO:0002209) | 2.52639039 |
| 77 | neuromuscular synaptic transmission (GO:0007274) | 2.52501288 |
| 78 | locomotory exploration behavior (GO:0035641) | 2.52437296 |
| 79 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.51961151 |
| 80 | retinal ganglion cell axon guidance (GO:0031290) | 2.51930521 |
| 81 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.51282822 |
| 82 | central nervous system myelination (GO:0022010) | 2.51153198 |
| 83 | axon ensheathment in central nervous system (GO:0032291) | 2.51153198 |
| 84 | appendage development (GO:0048736) | 2.50972505 |
| 85 | limb development (GO:0060173) | 2.50972505 |
| 86 | neuron recognition (GO:0008038) | 2.50605563 |
| 87 | inner ear receptor stereocilium organization (GO:0060122) | 2.50226876 |
| 88 | auditory receptor cell stereocilium organization (GO:0060088) | 2.50067850 |
| 89 | neuronal action potential (GO:0019228) | 2.48812621 |
| 90 | photoreceptor cell development (GO:0042461) | 2.48810608 |
| 91 | tryptophan metabolic process (GO:0006568) | 2.47957391 |
| 92 | regulation of action potential (GO:0098900) | 2.47449003 |
| 93 | smoothened signaling pathway (GO:0007224) | 2.46649253 |
| 94 | cornea development in camera-type eye (GO:0061303) | 2.46264496 |
| 95 | L-fucose catabolic process (GO:0042355) | 2.44986942 |
| 96 | fucose catabolic process (GO:0019317) | 2.44986942 |
| 97 | L-fucose metabolic process (GO:0042354) | 2.44986942 |
| 98 | tachykinin receptor signaling pathway (GO:0007217) | 2.44313052 |
| 99 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.43610360 |
| 100 | indole-containing compound metabolic process (GO:0042430) | 2.42846996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.45254735 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.42545046 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.25209989 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.85857481 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.75447717 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.59772548 |
| 7 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.56988121 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.52013784 |
| 9 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.18835339 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18133556 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.17547514 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.10798262 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.97495985 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.94355938 |
| 15 | FUS_26573619_Chip-Seq_HEK293_Human | 1.92349162 |
| 16 | P300_19829295_ChIP-Seq_ESCs_Human | 1.90114054 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87620629 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.83854350 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.80571627 |
| 20 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.79035789 |
| 21 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.74898533 |
| 22 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67193297 |
| 23 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65199091 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.62000376 |
| 25 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.61248286 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60866279 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 1.59847634 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.56853778 |
| 29 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55962000 |
| 30 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.55962000 |
| 31 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.55955430 |
| 32 | STAT3_23295773_ChIP-Seq_U87_Human | 1.54640915 |
| 33 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.53081065 |
| 34 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52001462 |
| 35 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.51969852 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.51525395 |
| 37 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.51481399 |
| 38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.49611634 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.47776781 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.45509935 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45388193 |
| 42 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.44491607 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.44315768 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.44127230 |
| 45 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42620287 |
| 46 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.42443765 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42152116 |
| 48 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.41840823 |
| 49 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.41072767 |
| 50 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.40575751 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39444246 |
| 52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39036284 |
| 53 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.37467544 |
| 54 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.37467544 |
| 55 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.35011723 |
| 56 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.33496088 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32963517 |
| 58 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.31901660 |
| 59 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.25702318 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.24790102 |
| 61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24649851 |
| 62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.24186450 |
| 63 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21847736 |
| 64 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.19928701 |
| 65 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.19273699 |
| 66 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19196683 |
| 67 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.19147995 |
| 68 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.18431307 |
| 69 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17869917 |
| 70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16694672 |
| 71 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.16000608 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11954363 |
| 73 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11735373 |
| 74 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09403239 |
| 75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.09305871 |
| 76 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.08586847 |
| 77 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.08586847 |
| 78 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08252178 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08206538 |
| 80 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07278952 |
| 81 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.05988558 |
| 82 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05080353 |
| 83 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03306084 |
| 84 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03306084 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02800084 |
| 86 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.00221041 |
| 87 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.99817537 |
| 88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99003079 |
| 89 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98237897 |
| 90 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98022125 |
| 91 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97782557 |
| 92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97648391 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97561210 |
| 94 | NCOR_22424771_ChIP-Seq_293T_Human | 0.97086800 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96254560 |
| 96 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96012131 |
| 97 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.95140006 |
| 98 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.94243957 |
| 99 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93938665 |
| 100 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93051938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.41414436 |
| 2 | MP0006276_abnormal_autonomic_nervous | 2.69219398 |
| 3 | MP0001968_abnormal_touch/_nociception | 2.68676840 |
| 4 | MP0002736_abnormal_nociception_after | 2.57424446 |
| 5 | MP0005423_abnormal_somatic_nervous | 2.56639354 |
| 6 | MP0009046_muscle_twitch | 2.49017947 |
| 7 | MP0009745_abnormal_behavioral_response | 2.38925945 |
| 8 | MP0003136_yellow_coat_color | 2.37896888 |
| 9 | MP0001984_abnormal_olfaction | 2.37497251 |
| 10 | MP0004859_abnormal_synaptic_plasticity | 2.26778546 |
| 11 | MP0005551_abnormal_eye_electrophysiolog | 2.19467021 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.19061937 |
| 13 | MP0004142_abnormal_muscle_tone | 2.10054995 |
| 14 | MP0001486_abnormal_startle_reflex | 2.08048681 |
| 15 | MP0002272_abnormal_nervous_system | 2.07267417 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.05678732 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.00157085 |
| 18 | MP0000569_abnormal_digit_pigmentation | 1.96952316 |
| 19 | MP0002735_abnormal_chemical_nociception | 1.93506446 |
| 20 | MP0002064_seizures | 1.93115213 |
| 21 | MP0001501_abnormal_sleep_pattern | 1.91668603 |
| 22 | MP0001529_abnormal_vocalization | 1.87232276 |
| 23 | MP0003122_maternal_imprinting | 1.84852093 |
| 24 | MP0002063_abnormal_learning/memory/cond | 1.82306685 |
| 25 | MP0003787_abnormal_imprinting | 1.78620362 |
| 26 | MP0002638_abnormal_pupillary_reflex | 1.78408574 |
| 27 | MP0000778_abnormal_nervous_system | 1.77052269 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.71466722 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.70656774 |
| 30 | MP0006292_abnormal_olfactory_placode | 1.70319265 |
| 31 | MP0001970_abnormal_pain_threshold | 1.70249606 |
| 32 | MP0008789_abnormal_olfactory_epithelium | 1.66710778 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.64137155 |
| 34 | MP0005499_abnormal_olfactory_system | 1.62419479 |
| 35 | MP0005394_taste/olfaction_phenotype | 1.62419479 |
| 36 | MP0002733_abnormal_thermal_nociception | 1.58616842 |
| 37 | MP0002102_abnormal_ear_morphology | 1.55329323 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.54398458 |
| 39 | MP0001485_abnormal_pinna_reflex | 1.53857279 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.53522019 |
| 41 | MP0005253_abnormal_eye_physiology | 1.53424242 |
| 42 | MP0000372_irregular_coat_pigmentation | 1.52918786 |
| 43 | MP0008877_abnormal_DNA_methylation | 1.51536036 |
| 44 | MP0004133_heterotaxia | 1.42058816 |
| 45 | MP0002938_white_spotting | 1.39487518 |
| 46 | MP0001905_abnormal_dopamine_level | 1.39310690 |
| 47 | MP0003121_genomic_imprinting | 1.38423810 |
| 48 | MP0002822_catalepsy | 1.37259254 |
| 49 | MP0003878_abnormal_ear_physiology | 1.34446440 |
| 50 | MP0005377_hearing/vestibular/ear_phenot | 1.34446440 |
| 51 | MP0000631_abnormal_neuroendocrine_gland | 1.34274057 |
| 52 | MP0004270_analgesia | 1.33514917 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.33488830 |
| 54 | MP0010386_abnormal_urinary_bladder | 1.28332120 |
| 55 | MP0006072_abnormal_retinal_apoptosis | 1.26625945 |
| 56 | MP0002184_abnormal_innervation | 1.25957747 |
| 57 | MP0003195_calcinosis | 1.25702863 |
| 58 | MP0008872_abnormal_physiological_respon | 1.23562038 |
| 59 | MP0005171_absent_coat_pigmentation | 1.23119709 |
| 60 | MP0004885_abnormal_endolymph | 1.22854682 |
| 61 | MP0002882_abnormal_neuron_morphology | 1.21598531 |
| 62 | MP0000955_abnormal_spinal_cord | 1.20327937 |
| 63 | MP0004043_abnormal_pH_regulation | 1.19871293 |
| 64 | MP0001440_abnormal_grooming_behavior | 1.19743489 |
| 65 | MP0004924_abnormal_behavior | 1.19279573 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.19279573 |
| 67 | MP0000026_abnormal_inner_ear | 1.15704757 |
| 68 | MP0003011_delayed_dark_adaptation | 1.15479480 |
| 69 | MP0002752_abnormal_somatic_nervous | 1.13491986 |
| 70 | MP0001963_abnormal_hearing_physiology | 1.12929574 |
| 71 | MP0005174_abnormal_tail_pigmentation | 1.11532615 |
| 72 | MP0005410_abnormal_fertilization | 1.03623461 |
| 73 | MP0004742_abnormal_vestibular_system | 1.02850025 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.02846013 |
| 75 | MP0003879_abnormal_hair_cell | 1.02485821 |
| 76 | MP0002928_abnormal_bile_duct | 1.00300058 |
| 77 | MP0004147_increased_porphyrin_level | 1.00063132 |
| 78 | MP0002229_neurodegeneration | 0.98024429 |
| 79 | MP0002909_abnormal_adrenal_gland | 0.94853357 |
| 80 | MP0003698_abnormal_male_reproductive | 0.91923127 |
| 81 | MP0000427_abnormal_hair_cycle | 0.91881358 |
| 82 | MP0002066_abnormal_motor_capabilities/c | 0.91277040 |
| 83 | MP0003137_abnormal_impulse_conducting | 0.90256898 |
| 84 | MP0002152_abnormal_brain_morphology | 0.90050435 |
| 85 | MP0005195_abnormal_posterior_eye | 0.89491815 |
| 86 | MP0003119_abnormal_digestive_system | 0.88577042 |
| 87 | MP0002234_abnormal_pharynx_morphology | 0.88245143 |
| 88 | MP0005670_abnormal_white_adipose | 0.86721835 |
| 89 | MP0004811_abnormal_neuron_physiology | 0.85115746 |
| 90 | MP0004145_abnormal_muscle_electrophysio | 0.84787948 |
| 91 | MP0001502_abnormal_circadian_rhythm | 0.84453440 |
| 92 | MP0002751_abnormal_autonomic_nervous | 0.82931786 |
| 93 | MP0008569_lethality_at_weaning | 0.82590732 |
| 94 | MP0003633_abnormal_nervous_system | 0.80535112 |
| 95 | MP0008995_early_reproductive_senescence | 0.79194309 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.78003429 |
| 97 | MP0003646_muscle_fatigue | 0.77562575 |
| 98 | MP0004858_abnormal_nervous_system | 0.77371672 |
| 99 | MP0000049_abnormal_middle_ear | 0.72484976 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.72411543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | True hermaphroditism (HP:0010459) | 4.51100907 |
| 2 | Pancreatic cysts (HP:0001737) | 4.48577664 |
| 3 | Pancreatic fibrosis (HP:0100732) | 4.44483010 |
| 4 | Molar tooth sign on MRI (HP:0002419) | 3.94046174 |
| 5 | Abnormality of midbrain morphology (HP:0002418) | 3.94046174 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 3.93298097 |
| 7 | Genetic anticipation (HP:0003743) | 3.92496481 |
| 8 | Medial flaring of the eyebrow (HP:0010747) | 3.81501821 |
| 9 | Nephronophthisis (HP:0000090) | 3.79030444 |
| 10 | Gait imbalance (HP:0002141) | 3.72673767 |
| 11 | Cystic liver disease (HP:0006706) | 3.45672204 |
| 12 | Congenital primary aphakia (HP:0007707) | 3.43070558 |
| 13 | Focal motor seizures (HP:0011153) | 3.40764420 |
| 14 | Abnormal ciliary motility (HP:0012262) | 3.35731186 |
| 15 | Nephrogenic diabetes insipidus (HP:0009806) | 3.26769338 |
| 16 | Abnormality of the renal medulla (HP:0100957) | 3.22833252 |
| 17 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.15528135 |
| 18 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.15528135 |
| 19 | Absent/shortened dynein arms (HP:0200106) | 3.14104868 |
| 20 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.14104868 |
| 21 | Sclerocornea (HP:0000647) | 3.12182926 |
| 22 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.09460269 |
| 23 | Focal seizures (HP:0007359) | 3.08725257 |
| 24 | Gaze-evoked nystagmus (HP:0000640) | 3.08705324 |
| 25 | Hyperventilation (HP:0002883) | 3.05114985 |
| 26 | Congenital stationary night blindness (HP:0007642) | 2.99872017 |
| 27 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.96935659 |
| 28 | Febrile seizures (HP:0002373) | 2.90697183 |
| 29 | Chronic hepatic failure (HP:0100626) | 2.90196569 |
| 30 | Myokymia (HP:0002411) | 2.86954815 |
| 31 | Vaginal atresia (HP:0000148) | 2.80075007 |
| 32 | Polyphagia (HP:0002591) | 2.79030449 |
| 33 | Genital tract atresia (HP:0001827) | 2.78538618 |
| 34 | Tubulointerstitial nephritis (HP:0001970) | 2.71916795 |
| 35 | Dialeptic seizures (HP:0011146) | 2.70177873 |
| 36 | Abnormality of the labia minora (HP:0012880) | 2.69690661 |
| 37 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.66313741 |
| 38 | Retinal dysplasia (HP:0007973) | 2.66220180 |
| 39 | Atonic seizures (HP:0010819) | 2.65485608 |
| 40 | Absence seizures (HP:0002121) | 2.63443815 |
| 41 | Postaxial foot polydactyly (HP:0001830) | 2.60870956 |
| 42 | Poor coordination (HP:0002370) | 2.50900677 |
| 43 | Hemiparesis (HP:0001269) | 2.50643041 |
| 44 | Attenuation of retinal blood vessels (HP:0007843) | 2.46647213 |
| 45 | Congenital hepatic fibrosis (HP:0002612) | 2.45346568 |
| 46 | Abnormal drinking behavior (HP:0030082) | 2.45221752 |
| 47 | Polydipsia (HP:0001959) | 2.45221752 |
| 48 | Anencephaly (HP:0002323) | 2.44579211 |
| 49 | Abnormality of the renal cortex (HP:0011035) | 2.43637055 |
| 50 | Occipital encephalocele (HP:0002085) | 2.42149048 |
| 51 | Rhinitis (HP:0012384) | 2.40058862 |
| 52 | Failure to thrive in infancy (HP:0001531) | 2.34460105 |
| 53 | Absent speech (HP:0001344) | 2.31729237 |
| 54 | Type II lissencephaly (HP:0007260) | 2.29910896 |
| 55 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.27492772 |
| 56 | Decreased central vision (HP:0007663) | 2.24836868 |
| 57 | Epileptic encephalopathy (HP:0200134) | 2.22106485 |
| 58 | Pendular nystagmus (HP:0012043) | 2.18977702 |
| 59 | Specific learning disability (HP:0001328) | 2.17301359 |
| 60 | Male pseudohermaphroditism (HP:0000037) | 2.16762947 |
| 61 | Retinitis pigmentosa (HP:0000510) | 2.16719882 |
| 62 | Tubular atrophy (HP:0000092) | 2.16705780 |
| 63 | Broad-based gait (HP:0002136) | 2.13985624 |
| 64 | Postaxial hand polydactyly (HP:0001162) | 2.11363940 |
| 65 | Abnormality of macular pigmentation (HP:0008002) | 2.08480716 |
| 66 | Lissencephaly (HP:0001339) | 2.06706874 |
| 67 | Preaxial hand polydactyly (HP:0001177) | 2.06061134 |
| 68 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.04933678 |
| 69 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.02239970 |
| 70 | Abolished electroretinogram (ERG) (HP:0000550) | 2.00667913 |
| 71 | Increased corneal curvature (HP:0100692) | 1.94986532 |
| 72 | Keratoconus (HP:0000563) | 1.94986532 |
| 73 | Narrow forehead (HP:0000341) | 1.90027806 |
| 74 | Furrowed tongue (HP:0000221) | 1.87158750 |
| 75 | Broad foot (HP:0001769) | 1.86142654 |
| 76 | Cerebellar dysplasia (HP:0007033) | 1.85202335 |
| 77 | Acute necrotizing encephalopathy (HP:0006965) | 1.83812307 |
| 78 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.81487054 |
| 79 | Polyuria (HP:0000103) | 1.80712656 |
| 80 | Tubulointerstitial abnormality (HP:0001969) | 1.80503397 |
| 81 | Aganglionic megacolon (HP:0002251) | 1.80471126 |
| 82 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.78161463 |
| 83 | Bile duct proliferation (HP:0001408) | 1.77750928 |
| 84 | Abnormal biliary tract physiology (HP:0012439) | 1.77750928 |
| 85 | Severe visual impairment (HP:0001141) | 1.77538861 |
| 86 | Abnormality of binocular vision (HP:0011514) | 1.76105320 |
| 87 | Diplopia (HP:0000651) | 1.76105320 |
| 88 | Hyperglycinemia (HP:0002154) | 1.76075981 |
| 89 | Epileptiform EEG discharges (HP:0011182) | 1.75723497 |
| 90 | Short foot (HP:0001773) | 1.75262959 |
| 91 | Limb dystonia (HP:0002451) | 1.74468376 |
| 92 | EEG with generalized epileptiform discharges (HP:0011198) | 1.74093675 |
| 93 | Hypsarrhythmia (HP:0002521) | 1.73997247 |
| 94 | Drooling (HP:0002307) | 1.71077602 |
| 95 | Astigmatism (HP:0000483) | 1.70387237 |
| 96 | Multicystic kidney dysplasia (HP:0000003) | 1.70227010 |
| 97 | Agitation (HP:0000713) | 1.69620928 |
| 98 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.69066107 |
| 99 | Hip dysplasia (HP:0001385) | 1.68186175 |
| 100 | Inability to walk (HP:0002540) | 1.67390355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.87695508 |
| 2 | MAP4K2 | 3.65312018 |
| 3 | MARK1 | 2.89647326 |
| 4 | CASK | 2.83316274 |
| 5 | MAPK13 | 2.55847811 |
| 6 | WNK3 | 2.28820601 |
| 7 | PINK1 | 2.26241238 |
| 8 | INSRR | 2.24692853 |
| 9 | EPHA4 | 2.24066382 |
| 10 | BMPR1B | 2.19937791 |
| 11 | ADRBK2 | 2.12057360 |
| 12 | MAP3K4 | 2.10813912 |
| 13 | CDK19 | 1.87047805 |
| 14 | NTRK3 | 1.79417063 |
| 15 | MAP2K7 | 1.77664338 |
| 16 | OXSR1 | 1.65592178 |
| 17 | BCR | 1.61121095 |
| 18 | DYRK2 | 1.59859810 |
| 19 | GRK1 | 1.56873941 |
| 20 | PLK2 | 1.54307849 |
| 21 | MAPK15 | 1.47154451 |
| 22 | NTRK2 | 1.44428751 |
| 23 | WNK4 | 1.42867077 |
| 24 | DAPK2 | 1.42262035 |
| 25 | PAK3 | 1.40645225 |
| 26 | NUAK1 | 1.38480711 |
| 27 | PRKCG | 1.33493734 |
| 28 | STK39 | 1.32247833 |
| 29 | TRIM28 | 1.28247007 |
| 30 | CSNK1G2 | 1.26900504 |
| 31 | CSNK1A1L | 1.22886875 |
| 32 | CSNK1G3 | 1.20227994 |
| 33 | PRKD3 | 1.15652574 |
| 34 | ZAK | 1.15076991 |
| 35 | MINK1 | 1.10346068 |
| 36 | ADRBK1 | 1.07256459 |
| 37 | BCKDK | 1.04354755 |
| 38 | PRKCE | 1.02737051 |
| 39 | PKN1 | 1.01104107 |
| 40 | CSNK1G1 | 1.00960686 |
| 41 | ACVR1B | 1.00675353 |
| 42 | TNIK | 0.98836855 |
| 43 | CAMK1 | 0.92744526 |
| 44 | MKNK2 | 0.90123526 |
| 45 | PNCK | 0.87355269 |
| 46 | DYRK1A | 0.84667423 |
| 47 | PHKG1 | 0.83945684 |
| 48 | PHKG2 | 0.83945684 |
| 49 | NME1 | 0.83138113 |
| 50 | CAMK2A | 0.78826544 |
| 51 | PAK6 | 0.76773671 |
| 52 | ERBB3 | 0.75791072 |
| 53 | STK16 | 0.74720089 |
| 54 | TNK2 | 0.73001710 |
| 55 | FER | 0.72020917 |
| 56 | FGFR2 | 0.70470462 |
| 57 | TLK1 | 0.70359207 |
| 58 | SIK2 | 0.69517136 |
| 59 | STK38L | 0.68033707 |
| 60 | EPHA3 | 0.66214112 |
| 61 | ERBB2 | 0.63453704 |
| 62 | CDK5 | 0.61362202 |
| 63 | MAP2K4 | 0.59593885 |
| 64 | UHMK1 | 0.58962451 |
| 65 | MKNK1 | 0.56330302 |
| 66 | LMTK2 | 0.55683715 |
| 67 | CSNK1A1 | 0.55648987 |
| 68 | STK11 | 0.55150368 |
| 69 | PTK2B | 0.53230714 |
| 70 | VRK1 | 0.53143274 |
| 71 | PRKCZ | 0.52865339 |
| 72 | TAOK3 | 0.52858586 |
| 73 | PRKACA | 0.52771572 |
| 74 | GRK5 | 0.51131285 |
| 75 | MAPKAPK5 | 0.50168905 |
| 76 | VRK2 | 0.49650653 |
| 77 | MUSK | 0.49188049 |
| 78 | CSNK1D | 0.47636768 |
| 79 | PRKAA1 | 0.45512274 |
| 80 | CAMK1G | 0.42590301 |
| 81 | PIK3CA | 0.41307648 |
| 82 | PRKACB | 0.40413468 |
| 83 | PRKCA | 0.40251383 |
| 84 | PLK4 | 0.39186700 |
| 85 | CAMKK2 | 0.38295232 |
| 86 | PRKCQ | 0.37759988 |
| 87 | MAP3K7 | 0.37375394 |
| 88 | LIMK1 | 0.37093799 |
| 89 | PRKCH | 0.35344427 |
| 90 | PLK1 | 0.34748916 |
| 91 | DYRK3 | 0.34531453 |
| 92 | PRKG1 | 0.34478580 |
| 93 | RPS6KA5 | 0.34182894 |
| 94 | TGFBR1 | 0.34156802 |
| 95 | SGK223 | 0.31681334 |
| 96 | SGK494 | 0.31681334 |
| 97 | CAMK2B | 0.31009345 |
| 98 | PRKCI | 0.30663972 |
| 99 | EPHB2 | 0.29483483 |
| 100 | CAMK4 | 0.29302547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.49191292 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.11720349 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.65731751 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.45225900 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.40091834 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.30432131 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.12600236 |
| 8 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.11370405 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.09010691 |
| 10 | Taste transduction_Homo sapiens_hsa04742 | 1.94339443 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.92719361 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.92049009 |
| 13 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.84494390 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.76325098 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.73724684 |
| 16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.67936818 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.66324174 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.66231401 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.65478858 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.64490052 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.59832508 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.54967384 |
| 23 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.54963035 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.54168266 |
| 25 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.50229933 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.49991546 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.46690290 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.46513814 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.45595471 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.45492532 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.39517629 |
| 32 | Homologous recombination_Homo sapiens_hsa03440 | 1.35516940 |
| 33 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32302173 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.28827685 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.27029012 |
| 36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.23478565 |
| 37 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.20833726 |
| 38 | Salivary secretion_Homo sapiens_hsa04970 | 1.17882023 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.17261108 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.11387168 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.08584612 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.08221267 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06272498 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.05430100 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.04360877 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.04280281 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99254662 |
| 48 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.98060363 |
| 49 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.95828525 |
| 50 | Protein export_Homo sapiens_hsa03060 | 0.93822274 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93537900 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92719335 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89679048 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.88482534 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86316320 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 0.84565327 |
| 57 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83987586 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.81883571 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78684806 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78633137 |
| 61 | Purine metabolism_Homo sapiens_hsa00230 | 0.78362051 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77985632 |
| 63 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.72294506 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.71935670 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68570935 |
| 66 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68340207 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67790326 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65728363 |
| 69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65320829 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65149418 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64462893 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62708028 |
| 73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59306271 |
| 74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.56385213 |
| 75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56018551 |
| 76 | Long-term depression_Homo sapiens_hsa04730 | 0.55788150 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55330052 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.53638062 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.53509390 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53004360 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52549882 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52479342 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49534339 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48596663 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48434278 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47674305 |
| 87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.47343635 |
| 88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.45118620 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44757297 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44703756 |
| 91 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44088242 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42896536 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.42114745 |
| 94 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41431832 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41180133 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40702298 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40640292 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40325916 |
| 99 | RNA degradation_Homo sapiens_hsa03018 | 0.38848694 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.38180801 |

